OCUL
USDOcular Therapeutix Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$11.200
High
$11.355
Low
$10.400
Volume
1.84M
Company Fundamentals
Market Cap
2.3B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
2.72M
Exchange
NGM
Currency
USD
52-Week Range
Related News
Ocular Therapeutix™ Reports Third Quarter 2025 Financial Results and Business Highlights
Recent Investor Day highlighted how AXPAXLI™ is positioned to redefine retina based on potential superiority label, market expansion, and immediate adoptability Announced today that SOL-R achieved target
TD Cowen Maintains Buy on Ocular Therapeutix, Raises Price Target to $20
TD Cowen analyst Tara Bancroft maintains Ocular Therapeutix with a Buy and raises the price target from $14 to $20.
Ocular Therapeutix™ to Report Third Quarter 2025 Financial Results on November 4, 2025
BEDFORD, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, "Ocular")), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that it plans
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.